• Explore /
  • Poster
  • / CpG island methylator phenotype and KRAS mutation status as prognostic markers in patients with resected colorectal cancer.

CpG island methylator phenotype and KRAS mutation status as prognostic markers in patients with resected colorectal cancer.

Abstract Poster

Authors

Dong-Hoe Koo

D. H. Koo

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

D. H. Koo , Y. S. Hong , K. Kim , J. Lee , H. Chang , Y. Kang , C. S. Yu , J. C. Kim , M. Kim , S. J. Jang , T. W. Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 29: 2011 (suppl; abstr 3595)

Abstract #

3595

Poster Bd #

17C

Abstract Disclosures